Article
In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobiprole-resistant isolates.
Diagnostic microbiology and infectious disease - 1 Apr 2020
Hawser Stephen, Kothari Nimmi, Karlowsky James A, Wiktorowicz Tatiana, Hamed Kamal
Abstract excerpt
Ceftobiprole was active (MIC, ≤2 mg/L) against most isolates (99.7%; 877/880) of methicillin-resistant Staphylococcus aureus from respiratory tract infections collected in 14 European countries during 2016-2017. Whole-genome sequence analysis showed that two of the three ceftobiprole-resistant (MIC, 4 mg/L) isolates identified were clonal complex 8 (CC8) and one was CC5, and that different mutations were present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.